Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuantum Data Regulatory News (MAST)

  • There is currently no data for MAST

Shares issue

22 May 2023 15:00

RNS Number : 2348A
Mast Energy Developments PLC
22 May 2023
 

Mast Energy Developments PLC

(Incorporated in England and Wales)

(Registration Number: 12886458)

Share code on the LSE: MAST

ISIN: GB00BMBSCV12

('MED' or 'the Company')

 

Dated: 22 May 2023

 

Mast Energy Developments PLC ('MED' or 'the Company')

 

Shares issue

 

Mast Energy Developments PLC, the UK-based multi-asset owner, developer, and operator in the rapidly growing flexible power market has today allotted 11,666,890 new MED shares of £0.001 each (the "Conversion Shares") following receipt of conversion notices from the institutional lender group under the terms of the recent reprofiling agreement (the "Reprofiling Agreement") on the balance of its outstanding loan facilities announced on its RNS of 17 May 2023.

 

The shares are being issued in respect of £34,662.125 in accrued interest and £50,000 in principal payment (total of £84,663.125) at an exercise price of £0.0072567 per Conversion Share in accordance with the terms of the Reprofiling Agreement.

 

Application will be made for the Conversion Shares to be admitted to the Standard List segment of the Official List and to trading on the main market of the London Stock Exchange plc ("Admission"). It is expected that Admission will become effective and dealings in the Fee Shares will commence at 8.00am on, or around, 26 May 2023.

 

Following Admission, the total issued share capital of the Company will consist of 229,119,619 ordinary shares in issue and this figure may be used by shareholders as the denominator for the calculations to determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules. The shareholding of MED's largest shareholder, Kibo Mining (Cyprus) Limited will reduce from 57.86% to 54.91% following Admission.

 

ENDS

This announcement contains inside information for the purposes of the UK version of the Market Abuse Regulation (EU No. 596/2014) as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 ('UK MAR'). Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

For further information please visit www.med.energy or contact:

 

Pieter Krügel

Info@med.energy

Mast Energy

Developments PLC

CEO

Jon Belliss

+44 (0)20 7399 9425

Novum Securities

Corporate Broker

Zainab Slemang van Rijmenant

zainab@lifacommunications.com

Lifa Communications

Investor & Media Relations Advisor

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOESEUFDEEDSELI
Date   Source Headline
19th Oct 20227:00 amRNSPyebridge Trading Update
5th Oct 20227:00 amRNSMED Acquires two Projects and Secures Funding
13th Sep 20222:05 pmRNSSecond Price Monitoring Extn
13th Sep 20222:00 pmRNSPrice Monitoring Extension
23rd Aug 20227:00 amRNSHalf-year Report
8th Aug 20229:46 amRNSTR-1: Notification of major holdings
29th Jul 20222:15 pmRNSPartial Settlement Shareholder Loan & Share Issue
13th Jul 202212:46 pmRNSAppointment of Director
5th Jul 20227:00 amRNSPyebridge Trading and Operational Update
20th May 20227:00 amRNSAppointment of Chief Executive Officer
16th May 202211:24 amRNSResults of Annual General Meeting
20th Apr 20227:00 amRNSNotice of AGM
7th Apr 20227:00 amRNSGeneral Update
31st Mar 20227:00 amRNSResults for the 15 month period ended 31 Dec 2021
24th Feb 20227:00 amRNSBordesley T-4 Capacity Market Auction Results
23rd Feb 20222:05 pmRNSSecond Price Monitoring Extn
23rd Feb 20222:00 pmRNSPrice Monitoring Extension
21st Feb 20229:00 amRNSPrice Monitoring Extension
2nd Dec 20212:36 pmRNSMED Share Issue
15th Nov 20217:00 amRNSPyebridge Steady State Operation and Production
20th Oct 20217:00 amRNSTerm Sheet for Project Development Funding Signed
7th Oct 20217:00 amRNSMED Completes Acquisition of Rochdale Power Ltd
1st Oct 20217:00 amRNSNew Board Appointment
2nd Sep 20217:00 amRNSUnaudited results for the 9 months ended June 2021
16th Aug 20217:00 amRNSMED Acquires Third Standby Generation Facility
12th Aug 202112:48 pmRNSPyebridge Correction of Address Particulars
12th Aug 20217:00 amRNSMED acquires 9 MW Pyebridge Facility
30th Jun 20217:00 amRNSAppointment of Joint Broker
10th Jun 20217:00 amRNSBordesley: Construction to Commence
26th May 20219:05 amRNSHalf-year Report
21st May 20217:00 amRNSBordesley Progresses to Construction-ready Status
6th May 20217:00 amRNSOperational Update
14th Apr 20217:00 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.